Drug
Arct 2138
Arct 2138: highest development phase Phase 1, developed by Arcturus Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Arcturus Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| ARCT-2138 NCT06125691 | Phase 1 | Influenza, Human |
Latest
No recent events.
Follow Arct 2138 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.